The Paula Takacs Foundation For Sarcoma Research
The Paula Takacs Foundation For Sarcoma Research's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $73,863 for Christine Wade, Executive Director - 2024 (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $75,807. It is higher than the D + F figure for 11 of 16 peer organizations selected under the disclosed tier Same NTEE sector (H12), nationwide + size band 0.67–1.5× revenue (approximately 69%; median $64,286). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for The Paula Takacs Foundation For Sarcoma Research, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE sector (H12), nationwide + size band 0.67–1.5× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| Twist Out Cancer | PA | $627,434 | $65,446 |
| Light Of Day Foundation Inc | NJ | $607,489 | $46,523 |
| Carson Leslie Foundation | TX | $603,892 | $63,125 |
| Tango2 Research Foundation Incorporated | CT | $603,857 | $90,382 |
| Sky Foundation Inc | MI | $596,092 | $130,786 |
| Hereditary Neuropathy Foundation Inc | NY | $655,296 | $66,236 |
| Connecticut Challenge Inc | CT | $549,831 | $186,541 |
| Treatments For Epilepsy And Symptoms Of | CA | $541,973 | $59,308 |
View the organization record and available filings on ProPublica